Condition: Frailty · Sponsor: VA Office of Research and Development
Frailty is defined as a greater susceptibility to stressors resulting from age-related impairments in adaptive biological systems. Frailty leads to poorer physical performance and functional capacity and higher risk of adverse outcomes including falls, hospitalization, and mortality. Resilience, defined as the capacity to recover from disruptions to homeostasis, is critical to successful aging because it precedes frailty and enhances adults' ability to maintain optimal health and function well into older age. Evidence- based therapies to help older adults enhance resilience are limited and the biological underpinnings contributing to improved resilience have not yet been fully characterized. To address this important need, the investigators will conduct a clinical trial to examine the benefits of center- and home-based high intensity interval training (HIIT) on functional capacity, frailty, and resilience, and also to identify novel biomarkers of resilience in older Veterans.
This description comes directly from the study's public registry record.
Kenneth L Seldeen, PhD · (716) 888-4869 · Kenneth.Seldeen@va.gov
Bruce R Troen, MD · (816) 922-2755 · Bruce.Troen@va.gov
Always discuss trial participation with your own doctor first.
| Kansas City VA Medical Center, Kansas City, MO | Kansas City, Missouri, United States | Recruiting |
| Kansas City VA Medical Center, Kansas City, MO | Kansas City, Missouri, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05625204